Kura Oncology, Inc.
KURA
$5.95
$0.223.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.11M | 53.88M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.11M | 53.88M | -- | -- | -- |
| Cost of Revenue | 55.97M | 155.35M | -- | -- | 36.27M |
| Gross Profit | -41.87M | -101.46M | -- | -- | -36.27M |
| SG&A Expenses | 22.84M | 24.07M | 18.18M | 16.68M | 18.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.81M | 76.34M | 59.88M | 56.40M | 54.45M |
| Operating Income | -64.70M | -22.46M | -59.88M | -56.40M | -54.45M |
| Income Before Tax | -57.20M | -17.20M | -54.40M | -50.84M | -49.53M |
| Income Tax Expenses | 226.00K | 2.02M | -- | -- | -- |
| Earnings from Continuing Operations | -57.43M | -19.22M | -54.40M | -50.84M | -49.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.43M | -19.22M | -54.40M | -50.84M | -49.53M |
| EBIT | -64.70M | -22.46M | -59.88M | -56.40M | -54.45M |
| EBITDA | -64.46M | -22.25M | -59.68M | -56.20M | -54.22M |
| EPS Basic | -0.66 | -0.22 | -0.63 | -0.59 | -0.59 |
| Normalized Basic EPS | -0.41 | -0.22 | -0.39 | -0.37 | -0.37 |
| EPS Diluted | -0.66 | -0.22 | -0.63 | -0.59 | -0.59 |
| Normalized Diluted EPS | -0.41 | -0.22 | -0.39 | -0.37 | -0.37 |
| Average Basic Shares Outstanding | 87.42M | 87.14M | 86.95M | 86.64M | 83.91M |
| Average Diluted Shares Outstanding | 87.42M | 87.14M | 86.95M | 86.64M | 83.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |